A MLs have stubbornly resisted attempts to improve overall outcome using chemotherapy, epitherapy and immunotherapy approaches, including stem cell transplantation. Passaro et al use intravital 2-photon microscopy to demonstrate that this may reflect too much concentration on the leukemic population and not enough on the angiocrine factors (growth factors, trophogens and chemokines) produced by bone marrow vascular endothelial cells hosting the leukemic blasts. They show that the latter induce vascular abnormalities, including leakiness and hypoxia, mediated by increased reactive oxygen and nitric oxide (NO) production, which is resistant to chemotherapy in patient-derived xenografts. NO inhibition reduced vascular permeability and improved both normal stem cell function and leukemic blast response to chemotherapy, thus raising promise for use of NO inhibitors against the angiocrine culprits in acute myeloid leukemogenesis.
